PMCB PharmaCyte Biotech
- 2.110
- -0.010-0.47%
PharmaCyte Biotech News
PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY
PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has
Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech
Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunities PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the
PharmaCyte Completes Tender Offer to Purchase Shares
PharmaCyte Biotech Announces Final Results of Tender Offer
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces the final results of its previously announced tender offer to acquire up to 7,750,00
PharmaCyte Biotech Shares Up 13% to 52-Week High After Cash Tender Offer
By Chris Wack PharmaCyte Biotech shares were up 13% to $3.10, its 52-week high, after the company said it launched a cash tender offer for up to 7.75 million shares at $3.25 a share. The stock is up
Organogenesis, Arcturus Top Healthcare Gainers; ImmunityBio, Dynatronics Among Losers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersSunshine Biopharma (NASDAQ:SBFM) shares rose 45.1% to $0.77 during Thursday's pre-market session. The company's market cap stands at $17.3 million. Jaguar Health (NASDAQ:JAGX) stock rose 28.19%
Express News | PharmaCyte Biotech Puts Up Cash Tender Offer of 7.75M Shares for $3.25 Per Share >PMCB
PharmaCyte Biotech Completes $35M Private Placement >PMCB
PharmaCyte Biotech Completes $35M Private Placement >PMCB
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
Concurrently, the Company Announces $35 Million Financing of Convertible Preferred Stock at $4.00 per ShareLAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Com
Omega Therapeutics (NASDAQ:OMGA) & PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Contrast
Omega Therapeutics (NASDAQ:OMGA – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two c
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 0.7%
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) traded down 0.7% during mid-day trading on Wednesday . The stock traded as low as $2.93 and last traded at $2.96. 33,345 shares traded hands during
PharmaCyte Biotech (OTCMKTS:PMCB) and Ocugen (NASDAQ:OCGN) Critical Review
Ocugen (NASDAQ:OCGN – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on t
Cortexyme (NASDAQ:CRTX) Versus PharmaCyte Biotech (OTCMKTS:PMCB) Critical Survey
PharmaCyte Biotech (OTCMKTS:PMCB – Get Rating) and Cortexyme (NASDAQ:CRTX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based o
Cortexyme (NASDAQ:CRTX) and PharmaCyte Biotech (OTCMKTS:PMCB) Financial Comparison
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses b
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 0.4%
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares traded up 0.4% on Tuesday . The company traded as high as $2.88 and last traded at $2.84. 33,197 shares traded hands during mid-day trading,
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 0.4% Higher
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating)'s stock price traded up 0.4% during trading on Tuesday . The stock traded as high as $2.88 and last traded at $2.84. 33,197 shares changed hands dur
GreenLight Biosciences (NASDAQ:GRNA) and PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Survey
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two b
Analysis
Price Target
No Data
